Live Breaking News & Updates on Khiron Life Sciences Corp Stock Exchange

Stay updated with breaking news from Khiron life sciences corp stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

KHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDER

TORONTO, May 6, 2023 /CNW/ - Khiron Life Sciences Corp. announced today that, further to its press release dated April 17, 2023, the Ontario Securities Commission has denied the Company s. | May 6, 2023 ....

United States , United Kingdom , Alvaro Torres , Michael Oconnor , Khiron Life Sciences Corp , Regulation Services Provider , Venture Exchange , Ontario Securities Commission , Life Sciences , Securities Commission , Chief Executive Officer , Chief Financial Officer , Financial Statements , National Policy , Management Cease , Failure To File Cease , Multiple Jurisdictions , Annual Filings , Statement Regardingforward Looking Statements , Canada Newswire , Khiron Life Sciences Corp Stock Exchange , Press Release , He Khrn Ca49374l3065 ,

Khiron Opens New Medical Cannabis Clinic in Colombia

New 4,000 sq.ft. facility becomes 4th medical cannabis clinic in Bogota
Khiron opens its 4th Zerenia-branded medical cannabis clinic in the city of Bogota The new clinic, with a capacity of up to. | January 31, 2022 ....

New York , United States , United Kingdom , Paola Ricardo , Franziska Katterbach , Khiron Europe , Alvaro Torres , Investment Decisions , Latam Communications , Europe Communications , Investor Relations Services , Regulation Services Provider , Khiron Life Sciences Corp , Venture Exchange , Life Sciences , Colombian Government , Investor Relations , York City , Chief Executive Officer , Although Khiron , Annual Information Form , Canada Newswire , Khiron Life Sciences Corp Stock Exchange , Press Release , P Khrn Ca49374l3065 ,

Khiron Life Sciences : Announces Resignation of Chief Financial Officer Swapan Kakumanu of RTB LLP appointed as Interim CFO

TORONTO, Oct. 1, 2021 /PRNewswire/ - Khiron Life Sciences Corp. , a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announced that Joel. | October 1, 2021 ....

United States , United Kingdom , Alvaro Torres , Joel Friedman , Swapan Kakumanu , Regulation Services Provider , Khiron Life Sciences Corp , Life Sciences , Latin America , Chief Financial Officer , Chief Executive Officer , Company Secretary , Board Member , Although Khiron , Annual Information Form , Khiron Life Sciences Corp Stock Exchange , Press Release , Hat Khrnf Ca49374l3065 ,

Khiron Life Sciences : to Host Second Quarter 2021 Conference Call on August 23, 2021

TORONTO, Aug. 17, 2021 /PRNewswire/ - Khiron Life Sciences Corp. , a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announces that it will. | August 17, 2021 ....

United States , United Kingdom , Elsa Navarro , Paola Ricardo , Franziska Katterbach , Khiron Europe , Alvaro Torres , Joel Friedman , Chris Naprawa , Regulation Services Provider , Company Second Quarter , Khiron Life Sciences Corp , Life Sciences , Latin America , Second Quarter , Khiron Chief Executive Officer , Khiron Chief Financial Officer , President Khiron Europe , Khiron Board , Chief Executive Officer , Although Khiron , Annual Information Form , Khiron Life Sciences Corp Stock Exchange , Press Release , T Khrnf Ca49374l3065 , ஒன்றுபட்டது மாநிலங்களில் ,

Khiron Life Sciences : Reports First Quarter 2021 Financial Results

Record revenues of $2.8 million in Q1 2021, a 49% increase from the prior year and 13% increase from Q4 2020 Record gross profits of $1.1 million, a 171% improvement over Q4 2020 and record. | May 27, 2021 ....

United States , United Kingdom , Elsa Navarro , Paola Ricardo , Khiron Europe , Alvaro Torres , Joel Friedman , Tejinder Virk , Chris Naprawa , International Financial Reporting Standards , Health Service , Khiron Academy , Health Services , Colombia Cancer League , Khiron Life Sciences Corp , Regulation Services Provider , Medical Cannabis Product , Khiron Life Sciences , Latin America , Key Financial , Medical Cannabis , Continuing Professional Development , Three Months Ending March , Chief Executive Officer , Cellen Therapeutics , Project Twenty ,